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Objective: To evaluate the incidence of urinary tract infections (UTIs) in infants with antenatal hydronephrosis (AHN).
Materials and Methods: A cohort of AHN patients admitted to our institution between 2003 and 2013 were
identified. Altogether 192 patients with nonrefluxing hydronephrosis (HN, n = 135), nonrefluxing
hydroureteronephrosis (HUN, n = 21), or vesicoureteral reflux (VUR, n = 36) were identified. Patients with
complex anomalies or neonatal decompression of the urinary tract were excluded. Information about UTIs
diagnosed among the AHN patients was collected and compared with data from 58 controls.
Results:During themedian follow-up time of 2.6 (0.3–11.2) years, 24 (13%) patients (15 (10%)males and 9 (19%)
females) and 2 (3%) controls experienced at least one UTI (p = 0.033). Eighteen (69%) UTIs were febrile. The
males had the first UTI at significantly younger age than the females (0.3, 0.0–1.7 years vs. 1.0, 0.4–4.8 years,
p = 0.010). UTI was detected in 15 (63%) patients with grade 4–5 VUR, in 8 (6%) patients with HN, and in one
(5%) patient with HUN (p-values b0.001, 0.726 and N0.999 against the controls). None of the patients with
grade ≤3 VUR had UTI. Fifty-eight percent of the patients with UTI were on antimicrobial prophylaxis. In five
(12%) cases UTI appeared within one week after voiding cystourethrography (VCUG).
Conclusions: Infants with AHN and grade 4–5 VUR had the highest risk of UTI. UTIs tented to bemore common in
females than inmales; however, males experiencedUTI at younger age than females. VCUG caused UTI in 2.3% in
our material.
Level of Evidence: III.
© 2017 Elsevier Inc. All rights reserved.The prevalence of fetal hydronephrosis (HN) in antenatal ultra-
sonography (US) is approximately 1 % [1]. Antenatal hydronephrosis
(AHN) may be caused by a variety of urological abnormalities from
transient dilatation of the renal collection system to severe urinary
tract obstruction and vesicoureteral reflux (VUR) [2,3]., Urinary tract ab-
normalities, particularly pyeloureteral obstruction (PUO), nonrefluxing
hydroureteronephrosis (HUN), and vesicoureteral reflux (VUR), have
been connected to increased risk of UTIs [4,5,6,7,8].
In this study, we evaluated retrospectively the frequency of UTI in a
cohort of childrenwith antenatally detected hydronephrosis. We aimed
primarily to study (1) the risk of UTIs in childrenwith different causes of
AHN (VUR grades 1–3, VUR grades 4–5, nonrefluxing HUN, and HN
alone) compared to children without any abnormality that is supposed
to associate with UTIs, and (2) bacterial etiology and resistance in UTIs.
Secondarily we analyzed the impact of surgical intervention on UTI risk
in AHN patients.HN, hydronephrosis; HUN,
US, ultrasonography; UTI, uri-
iding cystourethrography.
Surgery, Helsinki University
40 7079515.1. Materials and methods
All patients with urinary tract abnormalities (ICD-10: Q60.0–Q64.9
and N13.0–N13.9) diagnosed between January 2003 and December
2013 were identified from the database of the Helsinki University
Hospital using electronic search tools. We further selected manually
all patients who had antenatally detected hydronephrosis to exclude
patients who were diagnosed after UTI or other symptoms appearing
postnatally. The ethics committee of the Helsinki University Hospital
approved the study protocol.
A total of 192 patients with persistent HN (the postnatal antero-
posterior diameter (APD) of renal pelvis N7 mm), nonrefluxing HUN
(distal ureter visible on ultrasound examination), or VUR system were
identified and included in the study (Table 1). None of the patients
were circumcised. Renal US examinationwas performed on all patients,
renal scintigraphy on 161 patients and voiding cystourethrography
(VUCG) on 150 (78%) patients. VCUG was performed to a selected pa-
tient group according to our standard protocol: patients with (1) visible
ureter in US or (2) pelvis APD ≥10 mm, (3) HN in association with re-
duced size kidney, or (4) bilateral hydronephrosis.
VURwas classified according to international classification [9]. In the
case of bilateral VUR, the patient was classified according to the higher
Table 1
Total number of patients and gender distribution in AHN patients and controls.
Diagnostic group Boys Girls Total
VUR gr 1–3, n (%) 8 (67) 4 (33) 12
VUR gr 4–5, n (%) 20 (83) 4 (17) 24
Nonrefluxing HUN, n (%) 16 (76) 5 (24) 21
HN, n (%) 100 (74) 35 (26) 135
All patients, n (%) 144 (75) 48 (25) 192
Controls, n (%) 38 (66) 20 (34) 58
VUR, vesicoureteral reflux; HUN, hydroureteronephrosis; HN, hydronephrosis.
Number of patients at risk
Age (years) 0.00 2.00 4.00 6.00 8.00 10.00
VUR 1-3 12 9 5 1 0 0
VUR 4-5 24 9 4 0 0 0
HUN 21 13 8 5 0 0
HN 135 55 25 11 5 1
Control 58 41 20 12 4 1
VUR, vesicoureteral reflux; HUN, hydroureteronephrosis; HN, hydronephrosis
Fig. 1. The occurrence of UTI in controls patients and AHN patients in different diagnostic
groups.
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urogenital abnormalities, ureteroceles, or urethral obstructions.
The control group consisted of 58 patients with suspected urinary
tract abnormality and either normal postnatal renal US or abnormality
supposedly not exposing to UTI (renal agenesis (n = 16), dysplastic or
multicystic dysplastic kidney (n = 20), simple renal or ovarian cysts
(n = 4), renal or adrenal cystic tumor (n = 2), ectopic kidney (n = 5)
or adrenal hemorrhage (n = 1)). All patients with dysplastic kidneys
were investigated with US, VCUG, and scintigraphy to exclude contra-
lateral pathology.
Information about age, gender, antimicrobial prophylaxis, results of
imaging studies and possible urological surgery was collected. Antimi-
crobial prophylaxis was started according to our current protocol:
(1) in patients with grade 3–5 VUR until they were toilet trained,
(2) in patients with HN ≥10 mm of APD, or (3) in patients with dilated
ureterwithout VUR until the first year of life. Occurrence of UTI was col-
lected retrospectively from the patient journals and laboratory data-
base. The diagnosis of UTI was defined as growth of a single pathogen
on urine culture and significant pyuria (N60 × 10E9/L) in urinalysis. A
bacterial count of 100,000 or more colony forming units (CFU)/mL in
voided samples (clean catch urine, urine bag), ≥50,000 CFU/mL in a
catheter sample, and any bacterial growth in suprapubic aspiration
were considered significant. Bacterial growth in bag sample was con-
firmed by either suprapubic aspiration or catheter sample. In 13 pa-
tients the diagnosis was based on two consecutive bag urine samples
and in two patients in one bag sample. Both of these two patients had
clinical symptoms suggesting UTI, significant bacterial growth in urine
and pyuria (N250–2063 × 10E9/L). Febrile UTI was defined as verified
UTI together with fever (N38.5 °C), or CRP N35 mg/L [10]. The risk for
UTI was calculated in each patient group during the follow-up time in
our hospital. UTIs after surgery were analyzed separately in patients
requiring surgical intervention.
The occurrence of UTIs is presented with Kaplan–Meyer curves.
Patients' age and gender at the outset of thefirst UTIwere compared be-
tween different diagnostic groupswithMann–Whitney test. Categorical
variables were compared with Fisher's exact test. Statistical analyses
were done with SPSS statistical package (IBM SPSS statistics 22).2. Results
2.1. General findings
The median follow-up time for the AHN patients was 2.6 years
(range 0.3–11.2 years) and that for the controls was 3.3 years (range
0.2–10.3 years) (p = 0.533). Two (3%) out of the 58 controls and 24
(13%) of the 192 patients had UTI before any operative intervention
(p = 0.051). Females tented to have more UTIs than males (9/48
(19%) vs. 15/144 (10%), p = 0.243). The vast majority of the first-time
UTIs (17/24 (71%)) were diagnosed during the first year of life (Fig. 1).
The males had their first UTI at significantly younger age than the fe-
males (median 0.3 years; range 0.0–1.7 years vs. 1.0 years; range
0.4–4.8) years, p = 0.010). Nineteen (79%) of the 24 AHN patients and
the other control patient with UTI had pyelonephritis.2.2. UTIs in AHN subgroups
Patients with grade 4–5 VUR had significantly more UTIs than the
patients with HUN, HN, or the control patients (p b 0.001, b0.001,
b0.001 and b0.001 respectively). The UTI occurrence did not differ be-
tween the control patients and other patient groups except patients
with gross VUR (Table 2). Female genderwas a nonsignificant risk factor
for UTI.
In our study 13 patients with HN had APD of renal pelvis between 7
and 10 mm. The UTI occurrence of patients with HN did not differ from
controls when those particular patients were excluded (p = 0.720).
2.3. UTI bacteriology, recurrence and antimicrobial prophylaxis
Altogether 161 patients had initially continuous antibiotic prophy-
laxis. Twenty infections occurred during antibiotic prophylaxis. In 16
(80%) cases, the bacteria were resistant to the prophylactic antibiotic
(Table 3). Escherichia coli caused 17 (71%) of the 24 first-time infections
and only 4 (40%) of the 10 recurrent infections in the patients. In the
controls, both infections were caused by E. coli, which was sensitive to
all tested antibiotics.
Six of the 24 (25%) patientswith UTI had recurrent infectionwithout
or before any operative intervention. Four (67%) of them had grade 4–5
VUR, one (17%) hadHUN, and another had HN. Two patients with grade
4–5 VUR had two UTI recurrences and one child had three recurrent in-
fections. There were no verified UTI recurrences in the control patients.
Altogether 215 VCUGs were done for the patients and controls. In
five cases (2.3%), UTI was detected within one week after VCUG had
been performed. From all three of these VCUG-related infections were
first-time UTIs and two were recurrences. Four out of five patients had
grade 4–5 VURand one of themhadHN. The patientswith grade 4–5 re-
flux had pyelonephritis and the patientwith HN had cystitis. All five pa-
tients were on antibiotic prophylaxis during VCUG before the UTI.
According to our VCUG protocol patients receive therapeutic dose of
antibiotics for three days. The prophylaxis starts in the morning of the
examination day.
2.4. UTIs in AHN patients with surgical intervention
Forty-three (22%) patients underwent surgical intervention. Twelve
(28%) of these patients had had at least one UTI before the first
Table 2
Occurrence of UTI in AHN patients and in controls.
Females Age at UTI Males Age at UTI All patients p-Value⁎
n UTI (%) Median Range n UTI (%) Median Range n UTI (%)
VUR gr 1–3 4 (0) 8 (0) 12 (0) N0.999
VUR gr 4–5 4 (100) 2.7 0.7–4.8 20 (55) 0.4 0.0–1.7 24 (63) b0.001
HUN 5 (20) 1.0 16 (0) 21 (5) N0.999
HN 35 [11] 0.84 0.5–1.1 100 [4] 0.5 0.1–1.0 135 [6] 0.726
Controls 20 [5] 0.4 38 [3] 0.2 58 [3]
The data are presented in all patients and in females and males separately.
VUR, vesicoureteral reflux; HUN, hydroureteronephrosis; HN, hydronephrosis; UTI, urinary tract infection.
⁎ Fisher's exact test, controls vs. all patients.
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two patients with HN). Despite successful surgery, UTI occurred at
least once in 6 (14%) patients (in two cases after Deflux® treatment
for grade 4–5 VUR, in one patient after ureteric tapering and
neocystostomy because of obstructive HUN, and in 3 cases after
pyeloplasty). Four of the operated patients had their first UTI after the
surgical intervention. The median follow-up time after surgery was 2.9
(range 0.2–9.8) years and themedian UTI occurrence time after surgery
was 1.8 (range 0.1–7.5) years.
3. Discussion
In the present study, AHN was not found to be an independent risk
factor for UTI, but the risk is depended on the underlying diagnosis. Ac-
cording to our findings infants with grade 4–5 VUR had significantly
higher risk for UTIs than the control patients or any other patient
group. On the contrary, the childrenwith grade 1–3 VURhad no verified
UTIs. The patients with nonrefluxing HN had a nonsignificant tendency
to have more UTIs than the controls. There was also clear gender differ-
ence. Boys had UTIs at a significantly younger age than girls. However,
girls tended to have more UTIs altogether during the follow-up period,
but the differencewas not significant. Our patients had alsoUTIs despite
surgical treatment of grade 4–5 VUR or pyeloplasty for the patientswith
pyeloureteral obstruction. Sixty-three percent of the patients with
grade 4–5 VUR and 6% of HN patients had UTI before any surgical treat-
ment. After surgery 17% of the operated patients with grade 4–5 VUR
and 11% with HN patients had UTI.
AHN may be associated with congenital renal dysplasia but AHN
may also predispose to UTIs, which may in turn lead to further kidney
damage [5,11]. In one large studywith 822 patients with congenital uri-
nary tract anomalies, 22% of the patients experienced UTI during the
first year of life, the risk being increased particularly in girls [4]. In an-
other study, hospitalization was needed during the first year of life be-
cause of pyelonephritis in 5% of infants with antenatal HN and in 1% of
the patients without antenatal HN [7]. Our results are in line with
these observations showing that 14% of the AHN patients and 3% of
the controls had UTI during a median follow-up of about 3 years. It is
for note, that 59% of the UTIs occurred in the patients with grade 4–5
VUR being the only patient group with increased risk for UTI.
In recent reports, the cutoff of 10 mm in APD has been suggested
[12]. However, in children with significant nephrouropathies theTable 3
Bacteria causing urinary tract infection and their resistance in all infections and depending on
Bacteria All infections Trimethoprim N
n n Resistant n
Escherichia coli⁎ 24 11 11 0
Staphylococcus 5 4 3 0
Klebsiella† 3 2 1 0
Enterococcus fecalis 2 2 1 0
Coliform sp. 2 0 0 1
⁎ In one case there was additional growth of Streptococcus agalactiae.
† In one case there was additional growth of E. fecalis.postnatal APD may vary between 7 and 10 mm [13,14]. In the present
studywe primarily used 7mm as cutoff level. The data were reanalyzed
using 10 mm as cutoff level. However, no difference in the UTI preva-
lence could be found between these two cutoff levels.
The risk for UTIs seems to be very dependent on the underlying diag-
nosis in AHN patients. In our study, especially the patients with high-
grade VUR had an increased risk for UTIs, similarly to earlier studies
[8,15,16]. In the study by Evans et al. [8], 52% of the AHN patients with
VUR had UTI despite continuous antibiotic prophylaxis. In their study,
52 of 54 patients had grade II–V reflux. Higher grades of VUR have
also been linked to recurrent UTIs as well, similarly to our study [16].
In some studies, no connection is seen between antenatally detected
VUR and UTIs. However, in these studies either the grade of VUR was
not reported, or grade III VUR was interpreted as high-grade VUR
[17,18].
HN together with urinary tract obstruction has been shown to in-
crease the risk for UTIs [6,19]. It has also been shown that the severity
of HN is positively correlated with the UTI risk [6,19]. In the present
studywe did not divide the patients based on the degree of HN. The pa-
tients with isolated HN, especially girls, had a tendency toward more
UTIs than the control patients. However, this finding did not reach sta-
tistical significance. In our study, patients with HUN did not have an el-
evated risk for UTIs. However, in previous studies the results have been
controversial. In one prospective study the patients with HUN andmild
dilatation had a negligible risk for UTI whereas in another study there
was a connection between nonrefluxing dilated ureters and UTIs [6,20].
In some earlier studies continuous antibiotic prophylaxis (CAP) re-
duced the risk of febrile UTIs in children with AHN because of ureteral
dilatation, high-grade VUR, or ureterovesical junction obstruction
[5,21,22,23]. A recent systematic reviewconcluded that CAP is beneficial
only in patients with high-grade hydronephrosis [24]. The risk for UTI
was found to be 14.6% with antibiotic prophylaxis and 28.9% without
prophylaxis. Another recent study with 405 patients with AHN showed
that the risk for febrile UTI was 7.9% with antibiotic prophylaxis and
18.7% without antibiotic prophylaxis [5]. The risk factors for UTIs were
high-gradeVUR and ureterovesical obstruction. Themajor disadvantage
of antimicrobial prophylaxis is an increased risk for antibiotic-resistant
bacteria [22]. In our study, approximately half of the UTIs occurred dur-
ing CAP; however, the design of our study did not allow us to estimate
the effect of CAP because all of our patients were primarily put on
CAP. However, if the previous observations concerning the benefits ofantimicrobial prophylaxis.
itrofurantoin No prophylaxis
Resistant n Resistant
13 3 for trimethoprim and 1 for cefalotin
1 1 for trimethoprim
1
0
0 1 1 for cefalotin
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was observed in our study.
Our present study confirms the previous finding [8,15,16], that the
patients with grade 4–5 VUR have an increased risk for UTIs. Despite
this finding the justification for the evaluation of VUR remains contro-
versial. VCUGprobably causedUTI in 2.3% in ourmaterial andwas a pre-
disposing factor in 11% of all UTIs in the patient cohort. Accordingly, it
might be preferable to perform VCUGs only in the patients with
suspected high-grade VUR, and sufficient antibiotic prophylaxis should
be given before and after the investigation. In the study, most of the pa-
tients were on trimethoprim prophylaxis at the time of VUCG. In some
previous studies, the risk for UTI after VCUG has been 4–6% despite an-
tibiotic prophylaxis [17,25].
Our study has some limitations. VCUGwas performed in 77.1% of the
patients and it is therefore possible that some patients with refluxwere
missed. On the other hand, only three of 43 patients without VCUG had
an UTI. VCUGwas performed according to our selection criteria in order
to avoid unnecessary irradiation and distress for the patients and par-
ents. In patients without VCUG, US findings were not suggestive for
high grade VUR. Another caveat of the study are the nonuniform urine
sample collection methods. In addition to suprapubic aspiration sam-
ples, we accepted also urine bag samples and samples taken by sterile
catheterization. However, only urine bag samples with significant
bacterial growth of a single uropathogen together with pyuria were
considered as UTI. The major strength of this study is that we collected
a well-defined cohort of AHN patients who were carefully followed up
in a single center. None of the patients were lost from follow-up.
Because of our centralized health care system it is likely that we have
been able to collect all significant UTIs in this patient cohort. Additionally,
we had bacteriological verification of all UTIs.
4. Conclusions
Weconclude that infantswithAHN togetherwith grade 4–5VURare
at the highest risk for UTI. The infections are more common in females
but appear earlier in males. Seventy-one percent of first-time UTIs are
caused by E. coli; however, 60% of the UTI recurrences were caused by
non-E. coli pathogens, which should be taken into account in antimicro-
bial prophylaxis. The UTI recurrence rate was 25% before any operation
and 17% after surgical intervention.
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